These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 27068362)

  • 1. Using continuous glucose monitoring to assess contributions of premeal and postmeal glucose levels in diabetic patients treated with metformin alone.
    Lin SD; Su SL; Wang SY; Tu ST; Hsu SR
    Diabetes Metab; 2016 Nov; 42(5):336-341. PubMed ID: 27068362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Owens DR
    Diabetes Metab; 2013 Sep; 39(4):337-42. PubMed ID: 23993831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of postmeal exercise on postprandial glucose excursions in people with type 2 diabetes treated with add-on hypoglycemic agents.
    Erickson ML; Little JP; Gay JL; McCully KK; Jenkins NT
    Diabetes Res Clin Pract; 2017 Apr; 126():240-247. PubMed ID: 28284168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.
    Gao H; Xiao W; Wang C; Zhang J; Yang Y; Yang J; Yang W; Hong T
    Int J Clin Pract; 2008 May; 62(5):695-700. PubMed ID: 18412932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.
    Ascić-Buturović B; Kacila M
    Bosn J Basic Med Sci; 2008 Nov; 8(4):309-12. PubMed ID: 19125700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
    Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
    Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study.
    Tan ML; Manski-Nankervis JA; Thuraisingam S; Jenkins A; O'Neal D; Furler J
    BMC Endocr Disord; 2018 Jul; 18(1):47. PubMed ID: 30031385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: An analysis using continuous glucose monitoring.
    Bergenstal RM; Strock E; Mazze R; Powers MA; Monk AM; Richter S; Souhami E; Ahrén B
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exenatide once weekly versus daily basal insulin as add-on treatment to metformin with or without a sulfonylurea: a retrospective pooled analysis in patients with poor glycemic control.
    Grimm M; Li Y; Brunell SC; Blase E
    Postgrad Med; 2013 Sep; 125(5):101-8. PubMed ID: 24113668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmeal exercise blunts postprandial glucose excursions in people on metformin monotherapy.
    Erickson ML; Little JP; Gay JL; McCully KK; Jenkins NT
    J Appl Physiol (1985); 2017 Aug; 123(2):444-450. PubMed ID: 28522762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.
    Veltkamp SA; van Dijk J; Collins C; van Bruijnsvoort M; Kadokura T; Smulders RA
    Clin Ther; 2012 Aug; 34(8):1761-71. PubMed ID: 22795925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous glucose monitoring in glimipiride plus metformin treated type 2 diabetic patients during the month of Ramadan].
    Oueslati I; Ben Said R; Kammoun I; Haouat E; Ben Salem L; Turki Z; Ben Slama C
    Tunis Med; 2012 Oct; 90(10):735-9. PubMed ID: 23096516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic Control after Metformin Discontinuation in Diabetic Patients with a Declining Renal Function.
    Leyco T; Ryanputra D; Peh R; Ponce A; Khoo CM
    J Diabetes Res; 2017; 2017():2769819. PubMed ID: 29230420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic Profiling in Patients with Drug-Naïve Type 2 Diabetes by Continuous Glucose Monitoring.
    Mori H; Okada Y; Kawaguchi M; Otsuka T; Miyazaki M; Sonoda S; Sugai K; Uemura F; Tanaka K; Hajime M; Kurozumi A; Narisawa M; Torimoto K; Tanaka Y
    J UOEH; 2018; 40(4):287-297. PubMed ID: 30568080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients.
    Rocic B; Bajuk NB; Rocic P; Weber DS; Boras J; Lovrencic MV
    Clin Invest Med; 2009 Dec; 32(6):E322. PubMed ID: 20003839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should diabetic patients be asked to test their blood glucose 90 to 120 minutes after the beginning of their meals?
    Sachon C; Jacqueminet S; Hartemann-Heurtier A; Grimaldi A
    Diabetes Metab; 2006 Sep; 32(4):377-81. PubMed ID: 16977268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative contribution of diurnal and nocturnal glucose exposures to HbA1c in type 1 diabetes males: a pooled analysis.
    Campbell MD; West DJ; O'Mahoney LL; Pearson S; Kietsiriroje N; Holmes M; Ajjan RA
    J Diabetes Metab Disord; 2022 Jun; 21(1):573-581. PubMed ID: 35673512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.